Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / United Kingdom

Marie Skłodowska-Curie Action · Running

NanoProt4Cond Engineered Protein Nanoparticles for Targeted Modulation of Biomolecular Condensates in Cancer

Coordinator
The Chancellor Masters and Scholars of the University of Cambridge, United Kingdom
Runs
1 October 2025 to 30 September 2027
Status
Running
EU funding
€260k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101207019

What the project is doing

In the project's own words, from its summary on CORDIS.

Biomolecular condensates, formed by liquid-liquid phase separation (LLPS), play a pivotal role in diverse biological processes and diseases, including cancer. Despite their importance, it is still a challenge to understand the role of condensates in biological regulation. ""NanoProt4Cond"" aims at exploring the Wnt signalling pathway, deregulated in cancers like colorectal cancer, using the cutting-edge high-throughput technology ‘PhaseScan’ to investigate condensate formation by Wnt-related proteins.

After identifying the proteins driving condensate formation, the project will engineer consensus-designed tandem repeat proteins (RPs) as condensate modulators (c-mods) by grafting short linear peptide motifs (SLiMs) from Wnt-pathway proteins onto RPs, creating multi-valent and multi-functional c-mods. While nanoparticles have been widely studied for overcoming traditional therapy limitations, their interaction with biomolecular condensates remains unexplored. ""NanoProt4Cond"" will fuse the most promising c-mods with proteins that self-assemble into nanoparticles, creating engineered protein nanoparticles that offer precise control over multifunctionality and valency.

The c-mod protein nanoparticles (c-NPs) will be tuned to target and modulate condensates, unlocking novel therapeutic strategies for cancer treatment. This project will deepen the understanding of condensate formation within the Wnt pathway and contribute to novel cancer therapeutics. Hosted at the University of Cambridge, this MSCA PF will provide advanced technical training in protein design, molecular therapies, and biomolecular condensates, allowing the researcher to apply her expertise in nanomaterials and biomedicine while expanding her skills in supervision, project management, and proposal writing.""

Topics

Who is involved

OrganisationCityCountryRole
The Chancellor Masters and Scholars of the University of CambridgeCambridgeUnited KingdomCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI